Skye Bioscience, Inc. Interest Expense Nonoperating
Skye Bioscience, Inc. (SKYE) reported Interest Expense Nonoperating of $3.30 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-14
- Skye Bioscience, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $3.30K.
- Skye Bioscience, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $2.20K, a 51.45% increase year-over-year.
- Skye Bioscience, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $0.00.
- Skye Bioscience, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $0.00.
- Skye Bioscience, Inc. interest expense nonoperating for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Skye Bioscience, Inc. interest expense nonoperating for fiscal 2024 was $749.31K, a 17.32% decline from fiscal 2023.
- Skye Bioscience, Inc. interest expense nonoperating for fiscal 2023 was $906.27K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.30K 10-Q · filed 2026-08-14 | $5.50K 10-Q · filed 2026-08-14 | $5.50K derived: sum of 3 quarters · filed 2026-08-14 | $5.50K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $2.20K 10-Q · filed 2026-05-11 | $2.20K derived: sum of 2 quarters · filed 2026-05-11 | $2.20K derived: sum of 3 quarters · filed 2026-05-11 | $2.20K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 derived: sum of 2 quarters · filed 2026-03-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 10-K · filed 2026-03-10 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $0.00 10-Q · filed 2025-11-10 | -$45.46K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | -$45.46K derived: sum of 3 quarters · filed 2026-08-14 | -$136.23K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $1.45K 10-Q · filed 2026-05-11 | -$45.46K derived: sum of 2 quarters · filed 2026-05-11 | -$136.23K derived: sum of 3 quarters · filed 2026-05-11 | $313.82K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$46.91K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$137.68K derived: sum of 2 quarters · filed 2026-03-10 | $312.37K derived: sum of 3 quarters · filed 2026-03-10 | $749.31K 10-K · filed 2026-03-10 |
| 2024-09-30 | -$90.77K 10-Q · filed 2025-11-10 | $359.29K derived: sum of 2 quarters · filed 2025-11-10 | $796.22K 10-Q · filed 2025-11-10 | $1.23M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $450.05K 10-Q · filed 2025-08-07 | $886.99K 10-Q · filed 2025-08-07 | $1.32M derived: sum of 3 quarters · filed 2025-08-07 | $1.59M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $436.94K 10-Q · filed 2025-05-08 | $867.07K derived: sum of 2 quarters · filed 2025-05-08 | $1.14M derived: sum of 3 quarters · filed 2025-05-08 | $1.32M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $430.13K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $701.44K derived: sum of 2 quarters · filed 2025-03-20 | $887.87K derived: sum of 3 quarters · filed 2025-03-20 | $906.27K 10-K · filed 2025-03-20 |
| 2023-09-30 | $271.31K 10-Q · filed 2024-11-07 | $457.74K derived: sum of 2 quarters · filed 2024-11-07 | $476.13K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $186.43K 10-Q · filed 2024-08-09 | $204.83K 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |